Literature DB >> 4004889

Acute effects of pentobarbital-anaesthesia on bile secretion.

F Kuipers, T Dijkstra, R Havinga, W van Asselt, R J Vonk.   

Abstract

Male Wistar rats were equipped with permanent catheters in the bile duct and the duodenum under ether anaesthesia, at least seven days before the experiments. By this technique, the enterohepatic circulation can be interrupted for bile collection without direct surgical intervention. 14C-Pentobarbital (26.6 mumole/100 g body wt) was injected intraperitoneally immediately before interruption of the enterohepatic circulation (NBD, Non-Bile Diverted) or after eight days of bile diversion (BD, Bile Diverted). In NBD rats, bile flow and biliary bile acid excretion were significantly reduced during the first hour after pentobarbital administration when compared to unanaesthetized controls, but markedly increased thereafter. Pentobarbital treatment slightly decreased biliary bile acid excretion in BD rats, but caused a 60% increase in bile flow. Within four hours 22.3 +/- 0.4% and 26.0 +/- 2.7% of the injected radioactivity was excreted into bile in NBD and BD rats, respectively. The calculated osmotic activity of pentobarbital and its metabolites was 47.8 +/- 5.2 microliter/mumole in NBD rats and 37.8 +/- 1.3 microliter/mumole in BD rats. Consequently, pentobarbital treatment affected the bile acid independent fraction of bile flow (BAIF). The calculated BAIF was 2.68 microliter/min/100 g body wt in unanaesthetized animals, but 4.27 microliter/min/100 g body wt in pentobarbital treated NBD rats. Corresponding values for BD rats were 1.70 and 2.38 microliter/min/100 g body wt. It is concluded that pentobarbital anaesthesia affects bile production in the rat by direct and indirect means. Firstly, pentobarbital and its metabolites are rapidly excreted into bile and exert a significant choleretic effect, thereby increasing the BAIF. Secondly, pentobarbital anaesthesia retards the exhaustion of the intestinal bile acid pool, which leads to secondary changes in the biliary excretion process.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4004889     DOI: 10.1016/0006-2952(85)90642-2

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  7 in total

1.  Effect of adrenaline on biliary excretion of triiodothyronines in rats mediated by alpha 1-adrenoceptors and related to the inhibition of 5'-monodeiodination in liver.

Authors:  P Langer; O Földes
Journal:  J Endocrinol Invest       Date:  1988 Jul-Aug       Impact factor: 4.256

Review 2.  Biochemistry of bile secretion.

Authors:  R Coleman
Journal:  Biochem J       Date:  1987-06-01       Impact factor: 3.857

3.  Short- and long-term effects of biliary drainage on hepatic cholesterol metabolism in the rat.

Authors:  M J Smit; A M Temmerman; R Havinga; F Kuipers; R J Vonk
Journal:  Biochem J       Date:  1990-08-01       Impact factor: 3.857

4.  Contribution of newly synthesized cholesterol to rat plasma and bile determined by mass isotopomer distribution analysis: bile-salt flux promotes secretion of newly synthesized cholesterol into bile.

Authors:  R H Bandsma; F Stellaard; R J Vonk; G T Nagel; R A Neese; M K Hellerstein; F Kuipers
Journal:  Biochem J       Date:  1998-02-01       Impact factor: 3.857

5.  Dietary fish oil-induced changes in intrahepatic cholesterol transport and bile acid synthesis in rats.

Authors:  M J Smit; A M Temmerman; H Wolters; F Kuipers; A C Beynen; R J Vonk
Journal:  J Clin Invest       Date:  1991-09       Impact factor: 14.808

6.  The effect of felodipine on bile flow in pentobarbital anaesthetized rats and conscious rats receiving bile salt supplementation.

Authors:  S X Wang; T A Sutfin; C G Regårdh
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1992 Oct-Dec       Impact factor: 2.441

7.  Metabolite profiles of two [14C]-labelled catechol O-methyltransferase inhibitors, nitecapone and entacapone, in rat and mouse urine and rat bile.

Authors:  T Wikberg; A Vuorela
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1994 Apr-Jun       Impact factor: 2.441

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.